CONTEXT: Inadequate dietary protein intake has been implicated in sarcopenia. OBJECTIVE AND DESIGN: The objectives of this study were to determine whether: 1) chronic essential amino acid (EAA) supplementation improves postabsorptive muscle protein fractional synthesis rate (FSR), lean body mass (LBM), and one-repetition maximum muscle strength, and androgen receptor and IGF-I muscle protein expression; and 2) the acute anabolic response to EAA ingestion is preserved after a 3-month supplementation period. Using a randomized, double-blinded, placebo-controlled design, older women (68 +/- 2 yr) were assigned to receive either placebo (n = 7), or 15 g EAA/d [supplemented treatment group (SUP)] (n = 7) for 3 months. Metabolic outcomes were assessed in association with stable isotope studies conducted at 0 and 3 months. SETTING: The study was performed at The University of Texas Medical Branch General Clinical Research Center. RESULTS: Ingestion of 7.5 g EAA acutely stimulated FSR in both groups at 0 months (P < 0.05). Basal FSR at 3 months was increased in SUP only. The magnitude of the acute response to EAA was unaltered after 3 months in SUP. LBM increased in SUP only (P < 0.05). One-repetition maximum strength remained unchanged in both groups. Basal IGF-I protein expression increased in SUP after 3 months (P = 0.05), with no changes in androgen receptor or total and phosphorylated Akt, mammalian target of rapamycin, S6 kinase, and 4E-binding protein. CONCLUSIONS: EAA improved LBM and basal muscle protein synthesis in older individuals. The acute anabolic response to EAA supplementation is maintained over time and can improve LBM, possibly offsetting the debilitating effects of sarcopenia.
RCT Entities:
CONTEXT: Inadequate dietary protein intake has been implicated in sarcopenia. OBJECTIVE AND DESIGN: The objectives of this study were to determine whether: 1) chronic essential amino acid (EAA) supplementation improves postabsorptive muscle protein fractional synthesis rate (FSR), lean body mass (LBM), and one-repetition maximum muscle strength, and androgen receptor and IGF-I muscle protein expression; and 2) the acute anabolic response to EAA ingestion is preserved after a 3-month supplementation period. Using a randomized, double-blinded, placebo-controlled design, older women (68 +/- 2 yr) were assigned to receive either placebo (n = 7), or 15 g EAA/d [supplemented treatment group (SUP)] (n = 7) for 3 months. Metabolic outcomes were assessed in association with stable isotope studies conducted at 0 and 3 months. SETTING: The study was performed at The University of Texas Medical Branch General Clinical Research Center. RESULTS: Ingestion of 7.5 g EAA acutely stimulated FSR in both groups at 0 months (P < 0.05). Basal FSR at 3 months was increased in SUP only. The magnitude of the acute response to EAA was unaltered after 3 months in SUP. LBM increased in SUP only (P < 0.05). One-repetition maximum strength remained unchanged in both groups. Basal IGF-I protein expression increased in SUP after 3 months (P = 0.05), with no changes in androgen receptor or total and phosphorylated Akt, mammalian target of rapamycin, S6 kinase, and 4E-binding protein. CONCLUSIONS:EAA improved LBM and basal muscle protein synthesis in older individuals. The acute anabolic response to EAA supplementation is maintained over time and can improve LBM, possibly offsetting the debilitating effects of sarcopenia.
Authors: M A Fiatarone; E F O'Neill; N D Ryan; K M Clements; G R Solares; M E Nelson; S B Roberts; J J Kehayias; L A Lipsitz; W J Evans Journal: N Engl J Med Date: 1994-06-23 Impact factor: 91.245
Authors: Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini Journal: Ageing Res Rev Date: 2010-05-14 Impact factor: 10.895
Authors: M Tieland; R Franssen; C Dullemeijer; C van Dronkelaar; H Kyung Kim; T Ispoglou; K Zhu; R L Prince; L J C van Loon; L C P G M de Groot Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Gordon I Smith; Dennis T Villareal; Charles P Lambert; Dominic N Reeds; B Selma Mohammed; Bettina Mittendorfer Journal: J Appl Physiol (1985) Date: 2009-11-25
Authors: C Beaudart; V Rabenda; M Simmons; A Geerinck; I Araujo De Carvalho; J-Y Reginster; J Amuthavalli Thiyagarajan; O Bruyère Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: I Ottestad; A T Løvstad; G O Gjevestad; H Hamarsland; J Šaltytė Benth; L F Andersen; A Bye; A S Biong; K Retterstøl; P O Iversen; T Raastad; S M Ulven; K B Holven Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Melissa M Markofski; Kristofer Jennings; Kyle L Timmerman; Jared M Dickinson; Christopher S Fry; Michael S Borack; Paul T Reidy; Rachel R Deer; Amanda Randolph; Blake B Rasmussen; Elena Volpi Journal: J Gerontol A Biol Sci Med Sci Date: 2019-09-15 Impact factor: 6.053
Authors: A Mithal; J-P Bonjour; S Boonen; P Burckhardt; H Degens; G El Hajj Fuleihan; R Josse; P Lips; J Morales Torres; R Rizzoli; N Yoshimura; D A Wahl; C Cooper; B Dawson-Hughes Journal: Osteoporos Int Date: 2012-12-18 Impact factor: 4.507